INVESTORS' PRESENTATION OverviewNews Events & Presentations Financials Governance Stock Resources Progressive Care Announces Full Launch of New COVID-19 Digital Passport App JULY 20, 2021 MIAMI, FL – July 20, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of the Company’s new myVax Passport, developed in partnership with EagleForce Health, LLC (“EagleForce”). The myVax Passport app is a healthcare digital passport that allows PharmCoRx to securely upload and store COVID-19 testing and vaccination data for its customers. More importantly, the app automatically reports testing and vaccination data to the Florida Department of Health, allowing users to see results on Florida State’s official Healthy Together platform. myVax provides for a contactless patient journey for COVID-19 testing at Progressive Care testing sites. Patients can get test results in minutes by scanning a QR code from a mobile device, creating a profile, and accessing test results by logging into Pharmcorx.com or by downloading the myVax App and choosing PharmCoRx as their organization. “Progressive Care has become a true leader in the rapid COVID-19 testing and vaccination space over the past year, and we believe we will now be setting the gold standard for digital health passport services at a time of resurgent concerns linked to the Delta variant of the virus,” remarked Alan Jay Weisberg, CEO and Chairman of Progressive Care. “The new myVax Passport application streamlines a contactless testing experience. It’s extremely easy to use and offers enormous and expandable functionality.” Once a myVax profile has been created, patients have a secure way to store health records, including testing records, vaccination records, medications, vitals, and passport data. The app’s telehealth capability is almost ready to be launched as well. It is also capable of tracking vital health data from smart watches and other smart devices. The myVax Passport will serve as an easy and secure way to store and manage verifiable COVID-19 related records for traveling or work purposes. “It is critical that commercial businesses that rely on timely and accurate COVID test and vaccination data have a safe, secure and verifiable source for this data and our relationship with Progressive Care provides the capability for its member population,” said Stanley Campbell, CEO of EagleForce Health. Progressive Care testing sites have administered close to 10,000 tests during the first six months of this year alone. The Company has also administered approximately 1,500 vaccine doses so far this year. The Company’s Rapid PCR, Antigen, and Antibody Testing solutions are gaining strong momentum with international travelers, International Airlines, International and US Entertainment Companies, Chain Restaurants, and local healthcare communities. "Customers are no longer willing to wait for days to get COVID-19 test results," said Mr. Weisberg. "We are proud to offer a better solution: COVID-19 results delivered in under 60 minutes. This applies when testing is administered at a Progressive Care testing sites and it also applies when one of our highly trained staff members come to the outpatient site. This level of care, convenience, and quality underlines everything we do. And we look forward to expanding this customer-centric model into testing services involving other conditions, including sexually transmitted diseases, toxicology, and many other domains." For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media: Progressive Care Inc. https://www.facebook.com/ProgressiveCareUS/ https://twitter.com/ProgressCareUS PharmCoRx https://www.pharmcorx.com/get-tested-now https://www.facebook.com/pharmcorx/ https://twitter.com/PharmCoRx ClearMetrX https://www.clearmetrx.com/ https://www.facebook.com/clearmetrx/ About Progressive Care: Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. About MyVax MyVax™ National Immunization Management system is deployed and scaled to serve as a single national platform for the emergency authorization of the COVID-19 vaccines, the associated lab reports as well as the daily routine management of other vaccines and medications for chronic conditions. The national infrastructure operates at every point-of-sale pharmacy with real-time alerting functionality that reaches across state borders to assure the safety and efficacy of all patients while enabling self-monitoring and management of chronic conditions and medications. This platform is designed to promote adherence and self-management of disease including routine immunizations and preventive care with access to care team through HIPAA compliant Telehealth platform. MyVax™ is designed to provide every man, woman, and child access to their own COVID-19 Vaccination Information and Medical Information for 25 years. MyVax™ allows the patient to own their own data and receive real-time scheduling and alerts directly from any provider, pharmacy, or payer from anyplace in the nation. About EagleForce: EagleForce pedigree was established within the commercial and government health sectors and is recognized as a leading technology solution’s company providing a broad range of eligibility systems development, organizational and operational assistance to “Big Data Analytics” processing, interoperability, predictive analytics, and other IT functions. The Companies evidence-based eligibility & real-time monitoring systems have been deployed to solve some of the biggest technology challenges in the world. Today, the EagleForce solutions have been adopted by many leading healthcare companies including pharmaceutical manufacturers, PBMs, chain pharmacies and drug wholesalers. EagleForce Health delivers the most advanced evidence-based clinical insights and business intelligence for accurate and persistent information available today. Leveraging the secure technology that has provided knowledge and analytics to both the commercial and government industries for many years, EagleForce Health brings this high pedigree of advanced analytics, information sharing, security, and privacy to healthcare. Cautionary Disclosure Regarding Forward-Looking Statements Forward-Looking Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Public Relations Contact: Carlos Rangel carlosr@pharmcorx.com ‍ ‍ ‍ Investors' Presentation Full overview of RXMD's performance DOWNLOAD NOW CONTACT US: INFO@PROGRESSIVECAREUS.COM COMPANY OVERVIEW NEWS STOCK INVESTOR'S FAQ CONTACT US PRIVACY POLICY ACCREDITED AS SEEN ON COPYRIGHT 2020 © PROGRESSIVE CARE INC. FORWARD-LOOKING STATEMENTS – CERTAINSTATEMENTS INCLUDED IN THIS PRESENTATION THAT ARE NOT HISTORICAL OR CURRENT FACTS INCLUDING, BUT NOT LIMITED TO, THOSE RELATED TO OUR FINANCIAL AND BUSINESS EXPECTATIONS AND OUTLOOK, THE IMPACT OF THE EVOLVING AND UNCERTAIN HEALTHCARE ENVIRONMENT, STRATEGY AND GROWTHDRIVERS, UTILIZATION AND PATIENT VOLUME TRENDS, REVENUE VISIBILITY, ANTICIPATEDMEMBERRENEWALS OF GPO PARTICIPATION AGREEMENTS, CROSS AND UPSELL OPPORTUNITIES, ACQUISITIONACTIVITIES AND PIPELINE, REVENUE AVAILABLE UNDER CONTRACT, PURCHASESUNDEROUR SHARE REPURCHASE PROGRAM AND THE FINANCIAL IMPACT OF SHARE REPURCHASES, TAX REFORM AND COST SAVINGS EFFORTS, POTENTIAL DIVIDEND PAYMENTS, AND2020 FINANCIALGUIDANCE AND RELATED ASSUMPTIONS ARE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE FEDERALSECURITIES LAWS. FORWARD-LOOKING STATEMENTS MAY INVOLVE KNOWNAND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT MAY CAUSE THE ACTUAL RESULTS TO BE MATERIALLY DIFFERENT FROM HISTORICAL RESULTS OR FROM ANY FUTURE RESULTS OR PROJECTIONS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. ACCORDINGLY, READERSSHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD LOOKING STATEMENTS. READERS ARE URGED TO CONSIDER STATEMENTS IN THE CONDITIONAL OR FUTURE TENSES OR THAT INCLUDE TERMS SUCH AS “BELIEVES,” “BELIEF,” “EXPECTS,” “ESTIMATES,” “INTENDS,” “ANTICIPATES” OR “PLANS”TO BEUNCERTAINAND FORWARD-LOOKING.FORWARD-LOOKING STATEMENTS MAY INCLUDE COMMENTS REGARDING THE COMPANY ’S BELIEFS AND EXPECTATIONS AS TO FUTURE EVENTS AND TRENDS AFFECTING ITS BUSINESS AND ARE NECESSARILY SUBJECT TO UNCERTAINTIES, MANY OF WHICH ARE OUTSIDE COMPANY’S CONTROL. YOU SHOULD CAREFULLY READ COMPANY’S PERIODIC AND CURRENT FILINGS WITH THE OTC MARKETS FOR MORE INFORMATION ON POTENTIAL RISKS AND OTHER FACTORS THAT COULD AFFECT THE COMPANY AND ITS FINANCIAL CONDITION OR RESULTS OF OPERATIONS. FORWARD-LOOKING STATEMENTS SPEAKONLY AS OFTHE DATE THEY ARE MADE. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS. ‍NON-GAAP FINANCIALMEASURES–THIS PRESENTATIONINCLUDES CERTAIN “NON-GAAP FINANCIAL MEASURES” AS DEFINED IN REGULATION G UNDER THE SECURITIES EXCHANGE ACT OF 1934. SCHEDULES ARE ATTACHED THAT RECONCILE THE NON-GAAP FINANCIAL MEASURES INCLUDED IN THIS PRESENTATION TO THE MOST DIRECTLY COMPARABLE FINANCIAL MEASURES CALCULATEDAND PRESENTEDIN ACCORDANCEWITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN THE UNITED STATES. YOU SHOULD CAREFULLY READ PROGRESSIVE CARE’S PERIODIC AND CURRENTFILINGS ON THE OTCQB WEBSITE FOR DEFINITIONS AND FURTHER EXPLANATION AND DISCLOSURE REGARDING OUR USE OF NON-GAAP FINANCIAL MEASURES AND SUCH FILINGS SHOULD BE READ IN CONJUNCTION WITH THIS PRESENTATION.